investor.alkermes.com
Provided by Alexa ranking, investor.alkermes.com has ranked N/A in N/A and 200213th on the world. It is hoted in N/A with IP address 23.67.33.15. The home page has 0 external link.
SiteTOP Score: 81486
SiteTOP Rank: 26593
Top keyword related from Search Engine of investor.alkermes.com
Traffic Ranks of investor.alkermes.com
Owner: |
N/A |
RANK: |
200213 |
Country code: |
N/A |
Country name: |
N/A |
Rank on country: |
N/A |
Host: |
N/A |
Ip: |
23.67.33.15 |
Ref link: |
|
Extension: |
com |
Top URL related to investor.alkermes.com
-
1. Alkermes – A Global Biopharmaceutical Company
Link: http://www.alkermes.com/
Description: WEBApr 9, 2024 · Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the field of neuroscience.
DA: 36 PA: 37 MOZ Rank: 37
-
2. About Alkermes | Alkermes
Link: https://www.alkermes.com/about-us
Description: WEBWe have GMP manufacturing facilities in Wilmington, Ohio and Athlone, Ireland. Contact us. Alkermes strives to improve outcomes for the patients, families …
DA: 21 PA: 15 MOZ Rank: 24
-
3. Medicines, Disease Areas & Third-Party Products | Alkermes
Link: https://www.alkermes.com/medicines-and-focus
Description: WEBAlkermes has medicines for addiction, schizophrenia and bipolar I disorder, and treatments in development for neurological disorders such as …
DA: 89 PA: 89 MOZ Rank: 74
-
4. Research & Development, Approach & Pipeline | Alkermes
Link: https://www.alkermes.com/research-and-development
Description: WEBOur Approach. Our R&D approach is grounded in a thoughtful focus on real-world challenges faced by people living with complex and serious diseases. …
DA: 48 PA: 100 MOZ Rank: 9
-
5. Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of
Link: https://investor.alkermes.com/news-releases/news-release-details/alkermes-announces-fda-approval-lybalvitm-treatment
Description: WEBDUBLIN, June 1, 2021 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved …
DA: 22 PA: 66 MOZ Rank: 68